Dr. Yvonne A. Efebera, MD

Dr. Efebera practices at OhioHealth Mobile Mammography Unit in Columbus, Ohio.

Dr. Efebera's NPI, 1285612986, was assigned on January 4, 2006. Dr. Efebera graduated from Penn State College of Medicine in 1998. Dr. Efebera holds Ohio license 35.078732.

Dr. Efebera's primary practice is OhioHealth Mobile Mammography Unit, at 500 Thomas Lane, Suite 2A, Columbus, OH 43214. The practice phone is (614) 566-1111.

Dr. Efebera's primary practice is OhioHealth Mobile Mammography Unit in Columbus, Ohio. Dr. Efebera is also affiliated with OhioHealth Riverside Methodist Hospital. The medical group on file is OhioHealth Physician Group. Dmand AI also links Dr. Efebera to 3 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Efebera's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Efebera practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Efebera's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Efebera is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Efebera's licenses on file in 3 states: Ohio, Texas and Massachusetts.

Dmand AI lists chronic leukemia and multiple myeloma among the conditions Dr. Efebera treats.

CMS data shows 709 Medicare services from Dr. Efebera across 10 procedure codes in 2024, for 210 Medicare patients. Medicare paid $71,943 for them.

CMS counts 210 Medicare patients who saw Dr. Efebera in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Efebera's median patient age at 70, with 44% women.

In 2024, Dr. Efebera wrote 619 Medicare Part D claims for 154 patients. 80% of them were for generic drugs. CMS names the drug for 369 of them, across 16 drugs with 11 or more claims each, at $1,553,490 in total drug cost. In 2023, CMS named 253 claims across 12 drugs.

Dr. Efebera accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Efebera as offering telehealth.

Dmand AI links 149 papers to Dr. Efebera, published from 2007 to 2025. 2019 was the busiest year, with 12. The most frequent topics are Multiple Myeloma, Hematopoietic Stem Cell Transplantation and Antineoplastic Combined Chemotherapy Protocols. Dr. Efebera has published most often in Biol Blood Marrow Transplant. Dr. Efebera's most frequent co-authors are Don Michael Benson, MD, Craig C. Hofmeister, MD and Naresh Bumma, MD.

Dmand AI links Dr. Efebera to 15 clinical trials, 5 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Multiple Myeloma, Blood Protein Disorders and Graft vs Host Disease. Ohio State University Comprehensive Cancer Center sponsors the most, 4.

CMS Open Payments shows 190 general payments to Dr. Efebera from 25 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 55% of the total. Millennium Pharmaceuticals, Inc. paid the most, $63,892. It also lists 3 research payments totaling $5,683 from 2017 to 2024.

Dmand AI lists 1 award for Dr. Efebera, most recently CMS Stage 1 EHR in 2013.

Dr. Efebera graduated from Penn State College of Medicine in 1998. Dr. Efebera is a member of ACP and ASCO.

Dr. Efebera is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.